Diurnal variation of cadmium-induced mortality in mice

Journal of Toxicological Sciences

Volumn 37, Issue 1, 2012, Pages 191-196

  Miura, Nobuhiko ^a   Yanagiba, Yukie ^a   Ohtani, Katsumi ^a   Mita, Masaharu ^b   Togawa, Masako ^c   Hasegawa, Tatsuya ^c  

^a NATIONAL INSTITUTE OF OCCUPATIONAL SAFETY AND HEALTH   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c YAMANASHI INSTITUTE OF ENVIRONMENTAL SCIENCES   (Japan)

Author keywords

Cadmium; Chronotoxicology; Circadian rhythm; Clock gene; Diurnal variation

Indexed keywords

CADMIUM; CADMIUM CHLORIDE; GLUTATHIONE; METALLOTHIONEIN;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CADMIUM POISONING; CIRCADIAN RHYTHM; IMMUNE RESPONSE; LIGHT DARK CYCLE; LIVER LEVEL; MALE; MORTALITY; MOUSE; NONHUMAN; SURVIVAL RATE;

MUS;

EID: 84857127364     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.37.191     Document Type: Article

References (38)

1. Blanco, R.A., Ziegler, T.R., Carlson, B.A., Cheng, P.Y., Park, Y., Cotsonis, G.A., Accardi, C.J. and Jones, D.P. (2007): Diurnal variation in glutathione and cysteine redox states in human plasma. Am. J. Clin. Nutr., 86, 1016-1023.
2. Bork, U., Lee, W.K., Kuchler, A., Dittmar, T. and Thevenod, F. (2010): Cadmium-induced DNA damage triggers G(2)/M arrest via chk1/2 and cdc2 in p53-deficient kidney proximal tubule cells. Am. J. Physiol. Renal. Physiol., 298, F255-265.
3. Burioka, N., Fukuoka, Y., Koyanagi, S., Miyata, M., Takata, M., Chikumi, H., Takane, H., Watanabe, M., Endo, M., Sako, T., Suyama, H., Ohdo, S. and Shimizu, E. (2010): Asthma: Chronopharmacotherapy and the molecular clock. Adv. Drug Deliv. Rev., 62, 946-955.
4. Cambar, J., Cal, J.C., Desmouliere, A. and Guillemain, J. (1983): Circadian variations of the mortality of mice due to cadmium sulfate. C R Seances. Acad. Sci. III, 296, 949-952.
5. Cano, P., Poliandri, A.H., Jimenez, V., Cardinali, D.P. and Esquifino, A.I. (2007): Cadmium-induced changes in Per 1 and Per 2 gene expression in rat hypothalamus and anterior pituitary: effect of melatonin. Toxicol. Lett., 172, 131-136.
6. Chan, H.M. and Cherian, M.G. (1992): Protective roles of metallothionein and glutathione in hepatotoxicity of cadmium. Toxicology, 72, 281-290.
7. Chernyak, B.V., Khodjaev, E.Yu. and Kozlov, I.A. (1985): The oxidation of sulfhydryl groups in mitochondrial F1-ATPase decreases the rate of its inactivation by the natural protein inhibitor. FEBS Lett., 187, 253-256.
8. Cuypers, A., Plusquin, M., Remans, T., Jozefczak, M., Keunen, E., Gielen, H., Opdenakker, K., Nair, A.R., Munters, E., Artois, T.J., Nawrot, T., Vangronsveld, J. and Smeets, K. (2010): Cadmium stress: an oxidative challenge. Biometals, 23, 927-940.
9. Dardente, H. and Cermakian, N. (2007): Molecular circadian rhythms in central and peripheral clocks in mammals. Chronobiol. Int., 24, 195-213.
10. El-Sokkary, G.H., Nafady, A.A. and Shabash, E.H. (2010): Melatonin administration ameliorates cadmium-induced oxidative stress and morphological changes in the liver of rat. Ecotoxicol. Environ. Saf., 73, 456-463.
11. Griffith, O.W., Anderson, M.E. and Meister, A. (1979): Inhibition of glutathione biosynthesis by prothionine sulfoximine (S-n-propyl homocysteine sulfoximine), a selective inhibitor of gammaglutamylcysteine synthetase. J. Biol. Chem., 254, 1205-1210.
12. Haq, F., Mahoney, M. and Koropatnick, J. (2003): Signaling events for metallothionein induction. Mutat. Res., 533, 211-226.
13. Hardeland, R., Cardinali, D.P., Srinivasan, V., Spence, D.W., Brown, G.M. and Pandi-Perumal, S.R. (2011): Melatonin--a pleiotropic, orchestrating regulator molecule. Prog. Neurobiol., 93, 350-384.
14. Hermida, R.C., Ayala, D.E. and Calvo, C. (2005): Administration- time-dependent effects of antihypertensive treatment on the circadian pattern of blood pressure. Curr. Opin. Nephrol. Hypertens., 14, 453-459.
15. Jaeschke, H. and Wendel, A. (1985): Diurnal fluctuation and pharmacological alteration of mouse organ glutathione content. Biochem. Pharmacol., 34, 1029-1033.
16. Jensen, G.L. and Meister, A. (1983): Radioprotection of human lymphoid cells by exogenously supplied glutathione is mediated by gamma-glutamyl transpeptidase. Proc. Natl. Acad. Sci. USA, 80, 4714-4717.
17. Jimenez-Ortega, V., Cano-Barquilla, P., Scacchi, P.A., Cardinali, D.P. and Esquifino, A.I. (2011): Cadmium-induced disruption in 24-h expression of clock and redox enzyme genes in rat medial basal hypothalamus: prevention by melatonin. Front Neurol., 2, 1-9.
18. Kägi, J.H.R. (1993): Evolution, sturucture and chemical activity of class I metallothioneins: an overview. In Metallothionein III (Suzuki, K.T., Imura, N. and Kimura, M., eds.), pp. 29-55., Birkhauser Verlag, Basel, Switzerland.
19. Kim, C.Y., Lee, M.J., Lee, S.M., Lee, W.C. and Kim, J.S. (1998): Effect of melatonin on cadmium-induced hepatotoxicity in male Sprague-Dawley rats. Tohoku J. Exp. Med., 186, 205-213.
20. Ko, C.H. and Takahashi, J.S. (2006): Molecular components of the mammalian circadian clock. Hum. Mol. Genet., 15, R271-277.
21. Kobayashi, K., Kuroda, J., Shibata, N., Hasegawa, T., Seko, Y., Satoh, M., Tohyama, C., Takano, H., Imura, N., Sakabe, K., Fujishiro, H. and Himeno, S. (2007): Induction of metallothionein by manganese is completely dependent on interleukin- 6 production. J. Pharmacol. Exp. Ther., 320, 721-727.
22. Koyanagi, S., Nakagawa, H., Kuramoto, Y., Ohdo, S., Soeda, S. and Shimeno, H. (2003): Optimizing the dosing schedule of TNP- 470 [O-(chloroacetyl-carbamoyl) fumagillol] enhances its antitumor and antiangiogenic efficacies. J. Pharmacol. Exp. Ther., 304, 669-674.
23. Levi, F. and Schibler, U. (2007): Circadian rhythms: mechanisms and therapeutic implications. Annu. Rev. Pharmacol. Toxicol., 47, 593-628.
24. Matovic, V., Buha, A., Bulat, Z. and Dukic-Cosic, D. (2011): Cadmium toxicity revisited: focus on oxidative stress induction and interactions with zinc and magnesium. Arh. Hig. Rada. Toksikol., 62, 65-76.
25. Meister, A. (1984): New developments in glutathione metabolism and their potential application in therapy. Hepatology, 4, 739-742.
26. Miura, N. (2009): Individual susceptibility to cadmium toxicity and metallothionein gene polymorphisms: with references to current status of occupational cadmium exposure. Ind. Health, 47, 487-494.
27. Paier, B., Hagmuller, K., Noli, M.I., Gonzalez P M, Stiegler C., Zaninovich A.A (1993) Changes induced by cadmium administration on thyroxine deiodination and sulfhydryl groups in rat liver J. Endocrinol. 138, 219-224.
28. Palmiter, R.D. (1998): The elusive function of metallothioneins. Proc. Natl. Acad. Sci. USA, 95, 8428-8430.
29. Peters, G.J., Van Dijk, J., Nadal, J.C., Van Groeningen, C.J., Lankelma, J. and Pinedo, H.M. (1987): Diurnal variation in the therapeutic efficacy of 5-fluorouracil against murine colon cancer. In Vivo, 1, 113-117.
30. Pinot, F., Kreps, S.E., Bachelet, M., Hainaut, P., Bakonyi, M. and Polla, B.S. (2000): Cadmium in the environment: sources, mechanisms of biotoxicity, and biomarkers. Rev. Environ. Health, 15, 299-323.
31. Rikans, L.E. and Yamano, T. (2000): Mechanisms of cadmiummediated acute hepatotoxicity. J. Biochem. Mol. Toxicol., 14, 110-117.
32. Singhal, R.K., Anderson, M.E. and Meister, A. (1987): Glutathione, a first line of defense against cadmium toxicity. FASEB J., 1, 220-223.
33. Vasak, M. and Hasler, D.W. (2000): Metallothioneins: new functional and structural insights. Curr. Opin. Chem. Biol., 4, 177-183.
34. Waalkes, M.P., Coogan, T.P. and Barter, R.A. (1992): Toxicological principles of metal carcinogenesis with special emphasis on cadmium. Crit. Rev. Toxicol., 22, 175-201.
35. Wade, M.J., Davis, B.K., Carlisle, J.S., Klein, A.K. and Valoppi, L.M. (1993): Environmental transformation of toxic metals. Occup. Med., 8, 574-601.
36. Wimmer, U., Wang, Y., Georgiev, O. and Schaffner, W. (2005): Two major branches of anti-cadmium defense in the mouse: MTF-1/ metallothioneins and glutathione. Nucleic Acids Res., 33, 5715-5727.
37. Xie, J. and Shaikh, Z.A. (2006): Cadmium induces cell cycle arrest in rat kidney epithelial cells in G2/M phase. Toxicology, 224, 56-65.
38. Zhang, Y.K., Yeager, R.L. and Klaassen, C.D. (2009): Circadian expression profiles of drug-processing genes and transcription factors in mouse liver. Drug Metab. Dispos., 37, 106-115.